Opportunity ID: 320214

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-HL-20-021
Funding Opportunity Title: Trans-Agency Blood-Brain Interface Program (R61/R33 – Clinical Trials Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.233 — National Center on Sleep Disorders Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 03, 2019
Last Updated Date: Sep 03, 2019
Original Closing Date for Applications: Dec 21, 2021
Current Closing Date for Applications: Dec 21, 2021
Archive Date: Jan 26, 2022
Estimated Total Program Funding:
Award Ceiling: $425,000
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Native American tribal governments (Federally recognized)
City or township governments
Private institutions of higher education
Small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
State governments
For profit organizations other than small businesses
Special district governments
Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public housing authorities/Indian housing authorities
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support high risk/high reward research on the blood/vascular component and regulation of the neurovascular-blood unit (a.k.a., Blood-Brain Barrier; BBB) in normal and pathological states to create enhanced/modified platforms that more closely model the human BBB. Research addressing vascular, hemostatic, hematopoietic, and/or immune cell interaction across the Blood-Brain Interface is of particular interest. This initiative will serve to stimulate the development of a new field of science and re-define the neurovascular unit to also include the blood/vascular component to develop the next generation of pre-clinical human cellular model systems of the human BBB to complement research currently based on animal models.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-20-021.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or before January 24, 2022 PKG00260354 Sep 17, 2019 Jan 24, 2022 View
FORMS-E Use for due dates on or before May 24, 2020 PKG00254499 Sep 17, 2019 May 24, 2020 View
FORMS-G Use for due dates on or after January 25, 2022 PKG00270598 Nov 22, 2021 Dec 21, 2021 View

Package 1

Mandatory forms

320214 RR_SF424_2_0-2.0.pdf

320214 PHS398_CoverPageSupplement_5_0-5.0.pdf

320214 RR_OtherProjectInfo_1_4-1.4.pdf

320214 PerformanceSite_2_0-2.0.pdf

320214 RR_KeyPersonExpanded_2_0-2.0.pdf

320214 RR_Budget_1_4-1.4.pdf

320214 PHS398_ResearchPlan_4_0-4.0.pdf

320214 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

320214 RR_SubawardBudget30_1_4-1.4.pdf

320214 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

320214 RR_SF424_2_0-2.0.pdf

320214 PHS398_CoverPageSupplement_4_0-4.0.pdf

320214 RR_OtherProjectInfo_1_4-1.4.pdf

320214 PerformanceSite_2_0-2.0.pdf

320214 RR_KeyPersonExpanded_2_0-2.0.pdf

320214 RR_Budget_1_4-1.4.pdf

320214 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

320214 RR_SubawardBudget30_1_4-1.4.pdf

320214 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 3

Mandatory forms

320214 RR_SF424_5_0-5.0.pdf

320214 PHS398_CoverPageSupplement_5_0-5.0.pdf

320214 RR_OtherProjectInfo_1_4-1.4.pdf

320214 PerformanceSite_4_0-4.0.pdf

320214 RR_KeyPersonExpanded_4_0-4.0.pdf

320214 RR_Budget_3_0-3.0.pdf

320214 PHS398_ResearchPlan_4_0-4.0.pdf

320214 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

320214 RR_SubawardBudget30_3_0-3.0.pdf

320214 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T08:49:15-05:00

Share This Post, Choose Your Platform!

About the Author: